Summary
- Current Price
- As of today, KPTI price is $1.89, down -2.58% in the most recent trading session on
- Current Price All-Time High
- KPTI price is currently -99.74% below its historical high of $735.08 set on
- Market Cap
- KPTI current market cap is $43M, down -35.45% year-over-year
- Revenue
- KPTI current annual revenue is $146.07M, up +0.57% year-over-year
- Next Earnings
- The next earnings release for KPTI is on
Profile
| Metric | Value |
|---|---|
| Full Name | Karyopharm Therapeutics Inc. |
| Ticker | NASDAQ: KPTI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | karyopharm.com |
| Employees | 228 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.89 | ||
| Price, 1D Change | -2.58% | |
| $43M | ||
| - | ||
| - | ||
| 0.62 | ||
| $146.07M | ||
| Revenue, 1Y Change | +0.57% | |
| -$17.93 | ||
| EPS, 1Y Change | -90.58% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$17.93 | ||
| EPS Estimate | -$4.76 | N/A |
| EPS Est. Change | +73.47% | N/A |
| $146.07M | ||
| Revenue Estimate | $133.74M | N/A |
| Revenue Est. Change | -8.44% | N/A |
| $1.89 | ||
| Price Target | $7.00 | - |
| Price Tgt. Change | +270.37% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.62 | -$9.41 | -1,429.54% | |
| -$12.15 | -$17.93 | -47.55% | |
| -$4.76 | N/A | +73.47% | |
| -$3.21 | N/A | +82.12% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $150.43M | $145.24M | -3.45% | |
| $145.15M | $146.07M | +0.63% | |
| $133.74M | N/A | -8.44% | |
| $174.61M | N/A | +19.54% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -75.39% | ||
| -90.87% | ||
| -35.45% | ||
| -72.83% | ||
| +0.57% | ||
| -7.01% | ||
| -90.58% | ||
| -787.99% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.89 | ||
| $7.25 | ||
| $6.17 | ||
| $6.92 | ||
| $4.96 | ||
| -$1.19 | ||
| 0.62 | ||
| $0.37 | ||
| 25.72 | ||
| 98.92% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $146.07M | ||
| -$17.93 | ||
| $140.12M | ||
| 95.93% | ||
| -$90.71M | ||
| -62.10% | ||
| -$196.04M | ||
| -134.21% | ||
| -$90.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -0.77 | ||
| 1.12 | ||
| - | ||
| - | ||
| 2 | ||
| -21.29 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 0.29 | ||
| -0.13 | ||
| -2.85 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$292.93M | ||
| $63.74M | ||
| $117.46M | ||
| $90.27M | ||
| $410.38M | ||
| $0.00 | ||
| $226.90M | ||
| $0.00 | ||
| $4.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $342.11M | ||
| $230.83M | ||
| $6.25M | ||
| $105.21M | ||
| $296.00K | ||
| $0.00 | ||
| $43.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$75.37M | ||
| $43.38M | ||
| $30.05M | ||
| $0.00 | ||
| -$75.37M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Baird | → | |
| Rodman & Renshaw | ||
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
No data
Screeners with KPTI
FAQ
- What is the ticker symbol for Karyopharm Therapeutics Inc.?
- The ticker symbol for Karyopharm Therapeutics Inc. is NASDAQ:KPTI
- Does Karyopharm Therapeutics Inc. pay dividends?
- No, Karyopharm Therapeutics Inc. does not pay dividends
- What sector is Karyopharm Therapeutics Inc. in?
- Karyopharm Therapeutics Inc. is in the Healthcare sector
- What industry is Karyopharm Therapeutics Inc. in?
- Karyopharm Therapeutics Inc. is in the Biotechnology industry
- What country is Karyopharm Therapeutics Inc. based in?
- Karyopharm Therapeutics Inc. is headquartered in United States
- When did Karyopharm Therapeutics Inc. go public?
- Karyopharm Therapeutics Inc. initial public offering (IPO) was on November 6, 2013
- Is Karyopharm Therapeutics Inc. in the S&P 500?
- No, Karyopharm Therapeutics Inc. is not included in the S&P 500 index
- Is Karyopharm Therapeutics Inc. in the NASDAQ 100?
- No, Karyopharm Therapeutics Inc. is not included in the NASDAQ 100 index
- Is Karyopharm Therapeutics Inc. in the Dow Jones?
- No, Karyopharm Therapeutics Inc. is not included in the Dow Jones index
- When was Karyopharm Therapeutics Inc. last earnings report?
- Karyopharm Therapeutics Inc.'s most recent earnings report was on August 13, 2026
- When does Karyopharm Therapeutics Inc. report earnings?
- The next expected earnings date for Karyopharm Therapeutics Inc. is November 3, 2026
Data Sources & References
- KPTI Official Website www.karyopharm.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1503802/000119312526049397/0001193125-26-049397-index.htm
- KPTI Profile on Yahoo Finance finance.yahoo.com/quote/KPTI
- KPTI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kpti